PFC
IRWD icon

Phocas Financial Corp’s Ironwood Pharmaceuticals IRWD Stock Holding History

Phocas Financial Corp’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-253,694
Closed -$3.14M – 243
2022
Q4 		$3.14M Sell
253,694
-257
-0.1% -$2.92K 0.45% 90
2022
Q3 		$2.63M Buy
+253,951
New +$2.88M 0.41% 102

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Phocas Financial Corp's IRWD Position: Q1 2023 in Review

Phocas Financial Corp sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2023, closing a stake of 253,694 shares — an estimated $3.14M sold.

Phocas Financial Corp first reported a position in IRWD in Q3 2022 and held it in 2 quarters. The position peaked at $3.14M in Q4 2022. 254 funds tracked by Wall St. Rank hold IRWD as of Q1 2023.

  • Phocas Financial Corp reported no remaining Ironwood Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Phocas Financial Corp sold 253,694 Ironwood Pharmaceuticals shares in Q1 2023, an estimated $3.14M.
  • Phocas Financial Corp first reported a position in Ironwood Pharmaceuticals in Q3 2022 and held it in 2 quarters.
  • Phocas Financial Corp's Ironwood Pharmaceuticals position peaked at $3.14M in Q4 2022.
  • 254 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2023.

Based on Phocas Financial Corp's 13F filing for Q1 2023, filed 13 Apr 2023.